• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
COVID-19 Testing

A Possible Explanation for Differing Rates of COVID-19 Infection between Adults and Children

image_pdfFavoriteLoadingFavorite

PURPOSE:

  • Coronavirus disease 2019 (COVID-19) is an infection caused by the SARS-CoV-2 virus
  • The virus is known to target the angiotensin converting enzyme 2 (ACE2) co-receptor
  • Approximately <2% of COVID-19 cases are found in younger children
  • Bunyavanich et al. (JAMA, 2020) studied the ACE2 gene in nasal epithelium to determine if differing expression based on age may explain the distinct difference in infection rates between children and adults

METHODS:

  • Retrospective examination of nasal epithelium
  • Sample sources
    • Collected from individuals aged 4 to 60 years (2015-2018)
    • Initial collection was performed for a study on nasal biomarkers of asthma
  • Specimen collection at time of initial study
    • Cytology brush used to collect samples | Specimens stored and then RNA extracted within 6 months | Batch sequenced in 2018
  • For the present study
    • ACE2 gene expression was measured (amount of RNA indicates quantitative expression of a gene)
    • Adjustments made for co-variates (sex and asthma)
    • Age categories: <10 years | 10 to 17 years | 18 to 24 years | Adults (≥25 years)

RESULTS:

  • 305 individuals included
    • Ages: 4 to 60 years
    • Balanced between males and females
    • 49.8% had asthma (due to aim of the original study)
  • ACE2 gene expression was dependent on age | Lowest in younger children and increased with age (measured in mean log2 counts per million; P value calculated vs <10 year group)
    • <10 years (n=45): 2.40 (95% CI, 2.07 to 2.72)
    • 10 to 17 years (n=185): 2.77 (95% CI, 2.64 to 2.90; P=.01)
    • 18 to 24 years (n=46): 3.02 (95% CI, 2.78 to 3.26; P<.001)
    • Adults (n=29): 3.09 (95% CI, 2.83 to 3.35; P≤.05)
  • Tests for trend: Significant linear trend for change in ACE2 expression with advancing age group (P ≤ .05)
  • The above findings were independent of sex and asthma

CONCLUSION:

  • This study demonstrates that ACE2 gene expression in nasal epithelium is significantly lower in younger children and this finding trends to adulthood
  • The authors point out that nasal epithelium is “the first point of contact for SARS-CoV-2 and the human body” and that “Lower ACE2 expression in children relative to adults may help explain why COVID-19 is less prevalent in children”

Learn More – Primary Sources:

Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults

Get COVID-19 Research Summaries Direct to Your Phone, with ObGFirst

Try it Free »

image_pdfFavoriteLoadingFavorite
< Previous
All COVID-19 Testing Posts
Next >

Related ObG Topics:

COVID-19, ACE Inhibitors and ARBs: Professional Guidance and Evidence Update
COVID-19 Guidance: Key Highlights for Healthcare Professionals

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Download Your ObG App
HERE!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site